MAHON PAUL A (CIK 1231589) reported 280 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy UTHR (8,300 shares), Sell UTHR (658 shares), Sell UTHR (258 shares), Sell UTHR (384 shares), Sell UTHR (1,467 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 8,300 | $1.2M |
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 658 | $360,585 |
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 258 | $141,573 |
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 384 | $211,209 |
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,467 | $808,751 |
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,818 | $1.0M |
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 2,201 | $1.2M |
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 299 | $165,779 |
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 990 | $550,267 |
| 2026-07-02 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 225 | $125,181 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 958 | $515,431 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,715 | $921,027 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 8,300 | $1.2M |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,305 | $703,937 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 798 | $431,118 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 950 | $514,192 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 160 | $86,712 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 480 | $261,246 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 157 | $85,745 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 881 | $482,476 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 496 | $272,261 |
| 2026-06-18 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 400 | $220,696 |
| 2026-05-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 300 | $43,809 |
| 2026-05-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 8,000 | $1.2M |
| 2026-05-21 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 110 | $61,129 |
Source: SEC Form 4 filings · as of 2026-07-02